Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Medivation plans pivotal confirmatory phase III Dimebon trial in AD

Jan. 30, 2008

FDA accepts sNDA for Fentora for management of breakthrough pain

Jan. 30, 2008

Nabilone improves pain, quality of life in fibromyalgia patients

Jan. 30, 2008

Asenapine demonstrates long-term efficacy in bipolar disorder

Jan. 30, 2008

Recent patents disclose novel neuropsychiatric agents

Jan. 30, 2008

Successful gene transfer via lumbar puncture alleviates chronic pain in rats

Jan. 29, 2008

Quantum Genomics and INSERM to codevelop QGC-002 for stroke and cardiac ischemia

Jan. 29, 2008

Recent patents report novel analgesic agents

Jan. 29, 2008

Genome-wide analysis approach potentially useful to identify predictors of response to MS therapy

Jan. 29, 2008

Promising preclinical results for FGL in stress-induced cognitive deficits

Jan. 28, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...